Literature DB >> 31768406

Is There Less Opioid Abuse in States Where Marijuana Has Been Decriminalized, Either for Medicinal or Recreational Use? A Clin-IQ.

Aaron M Wendelboe1, Richard Mathew2, Tana Chongsuwat2, Elizabeth Rainwater2,3, Mark A Wendelboe2, Elizabeth Wickersham2, Ann F Chou2.   

Abstract

Opioid use, abuse, and associated mortality have reached an epidemic level. In some states, cannabis is being used to treat chronic pain. To examine the hypothesis that medical marijuana legislation may reduce adverse opioid-related outcomes if patients substitute cannabis for opioids for pain management, we conducted a clinical inquiry (Clin-IQ). We searched Ovid MEDLINE, Ovid MEDLINE In-Process, and Embase for studies using the search terms marijuana, cannabis, legal, marijuana smoking, medical marijuana, opioid-related disorders, cannabis use, medical cannabis, legal aspect, and opiate addiction. We included population-based articles published from January 1, 2012, through December 5, 2018, that assessed the relationship between marijuana use and decriminalization and the aforementioned opioid-related outcomes. Ten peer-reviewed studies met the inclusion criteria; 3 cross-sectional studies, 6 ecologic studies (ie, using aggregate data), and 1 retrospective cohort study. Eight studies reported associations between policies decriminalizing marijuana and reduced prescription opioid use, 1 study was inconclusive, and the retrospective cohort study reported an increase in adverse opioid-related outcomes. These results should be interpreted with caution given limitations associated with the studies' design. Results demonstrating association between marijuana decriminalization and opioid-related outcomes are mixed. Longitudinal studies are needed, and further analysis of this policy should continue to be tracked.
© 2019 Aurora Health Care, Inc.

Entities:  

Keywords:  analgesic; cannabis; decriminalization; ecologic analysis; epidemiology; medical marijuana; opioid

Year:  2019        PMID: 31768406      PMCID: PMC6827842          DOI: 10.17294/2330-0698.1704

Source DB:  PubMed          Journal:  J Patient Cent Res Rev        ISSN: 2330-068X


  20 in total

1.  A Proactive Response to Prescription Opioid Abuse.

Authors:  Robert M Califf; Janet Woodcock; Stephen Ostroff
Journal:  N Engl J Med       Date:  2016-02-04       Impact factor: 91.245

2.  The effect of medical marijuana laws on adolescent and adult use of marijuana, alcohol, and other substances.

Authors:  Hefei Wen; Jason M Hockenberry; Janet R Cummings
Journal:  J Health Econ       Date:  2015-03-23       Impact factor: 3.883

3.  Toxicosurveillance in the US opioid epidemic.

Authors:  Scott N Lucyk; Lewis S Nelson
Journal:  Int J Drug Policy       Date:  2017-07-18

4.  Behind Schedule - Reconciling Federal and State Marijuana Policy.

Authors:  Rebecca L Haffajee; Robert J MacCoun; Michelle M Mello
Journal:  N Engl J Med       Date:  2018-07-11       Impact factor: 91.245

5.  Cannabis Use and Risk of Prescription Opioid Use Disorder in the United States.

Authors:  Mark Olfson; Melanie M Wall; Shang-Min Liu; Carlos Blanco
Journal:  Am J Psychiatry       Date:  2017-09-26       Impact factor: 18.112

6.  Medical cannabis legalization and opioid prescriptions: evidence on US Medicaid enrollees during 1993-2014.

Authors:  Di Liang; Yuhua Bao; Mark Wallace; Igor Grant; Yuyan Shi
Journal:  Addiction       Date:  2018-08-06       Impact factor: 6.526

7.  Substitution of medical cannabis for pharmaceutical agents for pain, anxiety, and sleep.

Authors:  Brian J Piper; Rebecca M DeKeuster; Monica L Beals; Catherine M Cobb; Corey A Burchman; Leah Perkinson; Shayne T Lynn; Stephanie D Nichols; Alexander T Abess
Journal:  J Psychopharmacol       Date:  2017-04-04       Impact factor: 4.153

8.  Medical marijuana policies and hospitalizations related to marijuana and opioid pain reliever.

Authors:  Yuyan Shi
Journal:  Drug Alcohol Depend       Date:  2017-02-21       Impact factor: 4.492

Review 9.  Cannabis for the Treatment of Chronic Pain in the Era of an Opioid Epidemic: A Symposium-Based Review of Sociomedical Science.

Authors:  Dermot P Maher; Daniel B Carr; Kevin Hill; Brian McGeeney; Valerie Weed; William C Jackson; David J DiBenedetto; Edward M Moriarty; Ronald J Kulich
Journal:  Pain Med       Date:  2019-11-01       Impact factor: 3.750

10.  Medical Marijuana Laws Reduce Prescription Medication Use In Medicare Part D.

Authors:  Ashley C Bradford; W David Bradford
Journal:  Health Aff (Millwood)       Date:  2016-07-01       Impact factor: 6.301

View more
  2 in total

1.  Nonmedical Cannabis Use: Patterns and Correlates of Use, Exposure, and Harm, and Cancer Risk.

Authors:  Amy M Cohn; Benjamin C Blount; Mia Hashibe
Journal:  J Natl Cancer Inst Monogr       Date:  2021-11-28

Review 2.  Efficacy of cannabis-based medications compared to placebo for the treatment of chronic neuropathic pain: a systematic review with meta-analysis.

Authors:  Bradley Sainsbury; Jared Bloxham; Masoumeh Hassan Pour; Mariela Padilla; Reyes Enciso
Journal:  J Dent Anesth Pain Med       Date:  2021-11-26
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.